@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:> .
@prefix ns2: <http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:fcy3fn4c&rows=> .
@prefix ns3: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAzgx3wBJTfvW_dbmgw360W-lTzZ2ozfuwogB46r5tx9w#> .
@prefix this: <http://purl.org/np/RAzgx3wBJTfvW_dbmgw360W-lTzZ2ozfuwogB46r5tx9w> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C3887511> ns3:guide <https://uts.nlm.nih.gov/uts/umls/concept/C0003191> .
}

sub:provenance {
  sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" .
  
  sub:_version prov:value "2"^^xsd:integer .
  
  sub:assertion prov:generatedAtTime "2023-07-20T09:47:08.170220"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4692-1377;
    prov:wasDerivedFrom <https://doi.org/10.1007/s10067-021-05743-2> .
  
  rdf:OBJECT rdfs:label "with disease-modifying anti-rheumatic drugs ( DMARDs )" .
  
  rdf:OBJECT-POSITION rdfs:label "(35, 43)" .
  
  rdf:PREDICATE rdfs:label "guide" .
  
  rdf:PREDICATE-POSITION rdfs:label "47, 52" .
  
  rdf:SUBJECT rdfs:label "a paucity of high-quality evidence" .
  
  rdf:SUBJECT-POSITION rdfs:label "(35, 43)" .
  
  rdf:Statement rdfs:label "There is a paucity of high-quality evidence to guide The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs)." .
  
  rdfs:ABSTRACT-UID ns2:50 "fcy3fn4c" .
  
  rdfs:TRIPLE-UID ns1:fcy3fn4c-TRIPLE-ABSTRACT-7 "fcy3fn4c-TRIPLE-ABSTRACT-7" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0003191> rdfs:label "anti-rheumatic drugs" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C3887511> rdfs:label "evidence" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "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";
    npx:hasSignature "AIgBZ1PPL3K4dmYt0BdYVCtYk4g7vezZ5suBYqlTMke1tHTJGhXcYzGjhaxsXppVfRQQO1dNF5MREL08Y4o2TFeu0q+IzGSNGrQvH1JR/aWB9kXIrWFEqNxSQGYHTMVukijcdcAyn/EuMXctA9VHR1AFQ+rpp7kmV0Rtc+S6aRk01ucOCJ3+e9NR9WIg1ZQsqLPge4yfrxAsfTth2hWkxJ8KVjQxDtNhnsu0DzGRKfxOPIUoLTy4AxVQuhzHK9s3QsNi76NqaWuFrkm72xqDslOpqsOK3jfCSMAW7d22Zvayjml/sFfUVX5ogZEfJn7hAOrwyzV8KtlewxYHBo3B0RMZMIQcowvc/kVoEhzpkVB8UciCEPmL3v7CGxJxfAEcmr1IelmkBJvK3vDcVtJTjLNdwhS1Qlzc5lRqRlh4fOgjngoRvxII55Tw7k8ZF8t9Sp0ibo7as1CUnA2VhXU/eczq+2UiRQyu1xF+ye+h6X5ukGXPy7g2xyPnJJDKVhRs";
    npx:hasSignatureTarget this: .
  
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}